Registration number: 08102822

CGSkin Limited

Contents

Balance Sheet	1 to 2
Notes to the Unaudited Financial Statements	3 to 6

CGSkin Limited

(Registration number: 08102822)
Balance Sheet as at 30 June 2025

	Note	2025 £	2024 £
Fixed assets
Intangible assets	4	50,600	50,600
Current assets
Debtors	5	150	7
Cash at bank and in hand		1,191	3,283
		1,341	3,290
Creditors: Amounts falling due within one year	6	(4,660)	(154,023)
Net current liabilities		(3,319)	(150,733)
Net assets/(liabilities)		47,281	(100,133)
Capital and reserves
Called up share capital	7	182,828	42,443
Share premium reserve		51,312	44,250
Retained earnings		(186,859)	(186,826)
Shareholders' funds/(deficit)		47,281	(100,133)

For the financial year ending 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

CGSkin Limited

(Registration number: 08102822)
Balance Sheet as at 30 June 2025

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 23 December 2025 and signed on its behalf by:
 

................................................. Mr Simon O'Neill Director

CGSkin Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2025

1	General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
71-75 Shelton Street
Covent Garden
London
WC2H 9JQ
United Kingdom

These financial statements were authorised for issue by the Board on 23 December 2025.

2	Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Development costs

Costs relating to product development are recognised as an intangible asset in order to evenly match them against anticipated future revenue streams. Development costs are only capitalised if:

a) it is probable that the expected future economic benefits that are attributable to the development costs will flow to the company, and
b) costs can be measured reliably

Research costs are written off in the period in which they are incurred.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

CGSkin Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2025

3	Staff numbers

The average number of persons employed by the company (including directors) during the year, was 0 (2024 - 0).

4	Intangible assets

	Other intangible assets  £	Total £
Cost or valuation
At 1 July 2024	50,600	50,600
At 30 June 2025	50,600	50,600
Amortisation
Carrying amount
At 30 June 2025	50,600	50,600
At 30 June 2024	50,600	50,600

5

Debtors

	2025 £	2024 £
VAT Control account	150	7
	150	7

CGSkin Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2025

6

Creditors

Creditors: amounts falling due within one year

	Note	2025 £	2024 £
Due within one year
Trade creditors		900	77
Amounts owed to associates		2,840	-
Other related parties	8	-	108,017
Accruals and deferred income		920	6,500
Other creditors		-	39,429
		4,660	154,023